Heat shock protein 10 (Hsp10) in immune-related diseases: One coin, two sides

International Journal of Biochemistry and Molecular Biology

Volumn 2, Issue 1, 2011, Pages 47-57

  Jia, Haibo ^a   Halilou, Amadou I ^b   Hu, Liang ^b   Cai, Wenqian ^b   Liu, Jing ^b   Huang, Bo ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Autoimmune disease; Cancer; Hsp10; Location; Pregnancy

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD36 ANTIGEN; CD40 ANTIGEN; CHAPERONIN; EARLY PREGNANCY FACTOR; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 60; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN BCL 2; RECOMBINANT PROTEIN; SOMATOMEDIN C; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; CARCINOGENESIS; DOWN REGULATION; FERTILIZATION; GRAFT SURVIVAL; HUMAN; IMMUNOREGULATION; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; PREGNANCY; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TUMOR VASCULARIZATION;

EUKARYOTA;

EID: 79952172657     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Johnson BJ, Le TT, Dobbin CA, Banovic T, Howard CB, Flores Fde M, Vanags D, Naylor DJ, Hill GR and Suhrbier A. Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem 2005; 280:4037-4047.
2. Cappello F. HSP60 and HSP10 as diagnostic and prognostic tools in the management of exocervical carcinoma. Gynecol Oncol 2003; 91:661.
3. Corrao S, Campanella C, Anzalone R, Farina F, Zummo G, Conway de Macario E, Macario AJ, Cappello F and La Rocca G. Human Hsp10 and Early Pregnancy Factor (EPF) and their relationship and involvement in cancer and immunity: current knowledge and perspectives. Life Sci 2010; 86:145-152.
4. Cappello F, David S, Rappa F, Bucchieri F, Marasa L, Bartolotta TE, Farina F and Zummo G. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer 2005; 5:139.
5. Walsh A, Whelan D, Bielanowicz A, Skinner B, Aitken RJ, O'Bryan MK and Nixon B. Identification of the molecular chaperone, heat shock protein 1 (chaperonin 10), in the reproductive tract and in capacitating spermatozoa in the male mouse. Biol Reprod 2008; 78:983-993.
6. Shamaei-Tousi A, D'Aiuto F, Nibali L, Steptoe A, Coates AR, Parkar M, Donos N and Henderson B. Differential regulation of circulating levels of molecular chaperones in patients undergoing treatment for periodontal disease. PLoS One 2007; 2:e1198.
7. Sadacharan SK, Cavanagh AC and Gupta RS. Immunoelectron microscopy provides evidence for the presence of mitochondrial heat shock 10-kDa protein (chaperonin 10) in red blood cells and a variety of secretory granules. Histochem Cell Biol 2001; 116:507-517.
8. Macario AJ and Conway de Macario E. Sick chaperones, cellular stress, and disease. N Engl J Med 2005; 353:1489-1501.
9. Hansen JJ, Bross P, Westergaard M, Nielsen MN, Eiberg H, Borglum AD, Mogensen J, Kristiansen K, Bolund L and Gregersen N. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Hum Genet 2003; 112:71-77.
10. Cappello F, Bellafiore M, David S, Anzalone R and Zummo G. Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix. Cancer Lett 2003; 196:35-41.
11. Rodolico V, Tomasello G, Zerilli M, Martorana A, Pitruzzella A, Marino Gammazza A, David S, Zummo G, Damiani P, Accomando S, Conway de Macario E, Macario AJ and Cappello F. Hsp60 and Hsp10 increase in colon mucosa of Crohn's disease and ulcerative colitis. Cell Stress Chaperones 2010; 15:877-884.
12. Kim SW and Lee JK. NO-induced downregulation of HSP10 and HSP60 expression in the postischemic brain. J Neurosci Res 2007; 85:1252-1259.
13. Czarnecka AM, Campanella C, Zummo G and Cappello F. Heat shock protein 10 and signal transduction: a capsula eburnea of carcinogenesis? Cell Stress Chaperones 2006; 11:287-294.
14. Prudovsky I, Mandinova A, Soldi R, Bagala C, Graziani I, Landriscina M, Tarantini F, Duarte M, Bellum S, Doherty H and Maciag T. The nonclassical export routes: FGF1 and IL-1alpha point the way. J Cell Sci 2003; 116:4871-4881.
15. Arai M and Kuwajima K. Role of the molten globule state in protein folding. Adv Protein Chem 2000; 53:209-282.
16. Fujiwara K, Arai M, Shimizu A, Ikeguchi M, Kuwajima K and Sugai S. Folding-unfolding equilibrium and kinetics of equine betalactoglobulin: equivalence between the equilibrium molten globule state and a burst-phase folding intermediate. Biochemistry 1999; 38:4455-4463.
17. Mambula SS and Calderwood SK. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol 2006; 177:7849-7857.
18. Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR and Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. Proc Natl Acad Sci U S A 2004; 101:9745-9750.
19. Marty V, Medina C, Combe C, Parnet P snd Amedee T. ATP binding cassette transporter ABC1 is required for the release of interleukin-1beta by P2X7-stimulated and lipopolysaccharide- primed mouse Schwann cells. Glia 2005; 49:511-519.
20. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME and Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002; 3:995-1001.
21. Maizel A, Bensaude O, Prochiantz A and Joliot A. A short region of its homeodomain is necessary for engrailed nuclear export and secretion. Development 1999; 126:3183-3190.
22. Gupta S and Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 2007; 292:H3052-3056.
23. Cappello F, Conway de Macario E, Di Felice V, Zummo G and Macario AJ. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog 2009; 5:e1000552.
24. Endo T and Yamano K. Multiple pathways for mitochondrial protein traffic. Biol Chem 2009; 390:723-730.
25. Zhan R, Leng X, Liu X, Wang X, Gong J, Yan L, Wang L, Wang Y, Wang X and Qian LJ. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. Biochem Biophys Res Commun 2009; 387:229-233.
26. Horwich AL, Fenton WA, Chapman E and Farr GW. Two families of chaperonin: physiology and mechanism. Annu Rev Cell Dev Biol 2007; 23:115-145.
27. Ghosh JC, Dohi T, Kang BH and Altieri DC. Hsp60 regulation of tumor cell apoptosis. J Biol Chem 2008; 283:5188-5194.
28. Azem A, Diamant S, Kessel M, Weiss C and Goloubinoff P. The protein-folding activity of chaperonins correlates with the symmetric GroEL14(GroES7)2 heterooligomer. Proc Natl Acad Sci U S A 1995; 92:12021-12025.
29. Coluzza I, De Simone A, Fraternali F and Frenkel D. Multi-scale simulations provide supporting evidence for the hypothesis of intramolecular protein translocation in GroEL/GroES complexes. PLoS Comput Biol 2008; 4:e1000006.
30. Fiaux J, Bertelsen EB, Horwich AL and Wuthrich K. NMR analysis of a 900K GroEL GroES complex. Nature 2002; 418:207-211.
31. Meyer AS, Gillespie JR, Walther D, Millet IS, Doniach S and Frydman J. Closing the folding chamber of the eukaryotic chaperonin requires the transition state of ATP hydrolysis. Cell 2003; 113:369-381.
32. Xu Z, Horwich AL and Sigler PB. The crystal structure of the asymmetric GroEL-GroES-(ADP) 7 chaperonin complex. Nature 1997; 388:741-750.
33. Lin KM, Lin B, Lian IY, Mestril R, Scheffler IE and Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001; 103:1787-1792.
34. Levy-Rimler G, Bell RE, Ben-Tal N and Azem A. Type I chaperonins: not all are created equal. FEBS Lett 2002; 529:1-5.
35. Morton H, Hegh V and Clunie GJ. Immunosuppression detected in pregnant mice by rosette inhibition test. Nature 1974; 249:459-460.
36. Morton H, Rolfe B and Clunie GJ. An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet 1977; 1:394-397.
37. Cavanagh AC and Morton H. The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. Eur J Biochem 1994; 222:551-560.
38. Orozco C, Perkins T and Clarke FM. Plateletactivating factor induces the expression of early pregnancy factor activity in female mice. J Re prod Fertil 1986; 78:549-555.
39. Nancarrow CD, Wallace AL and Grewal AS. The early pregnancy factor of sheep and cattle. J Reprod Fertil Suppl 1981; 30:191-199.
40. Morton H, Morton DJ and Ellendorff F. The appearance and characteristics of early pregnancy factor in the pig. J Reprod Fertil 1983; 69:437-446.
41. Ohnuma K IK, Miyake Y-I, Tahakashi J and Yasuda Y. Detection of early pregnancy factor (EPF) in mare sera. Journal of Reproduction and Development 1996; 42:26-28.
42. Ghaffari Laleh V, Ghaffari Laleh R, Pirany N and Moghadaszadeh Ahrabi M. Measurement of EPF for detection of cow pregnancy using rosette inhibition test. Theriogenology 2008; 70:105-107.
43. Qin ZH and Zheng ZQ. Detection of early pregnancy factor in human sera. Am J Reprod Immunol Microbiol 1987; 13:15-18.
44. Zheng ZQ, Qin ZH, Ma AY, Qiao CX and Wang H. Detection of early pregnancy factor-like activity in human amniotic fluid. Am J Reprod Immunol 1990; 22:9-11.
45. Wang HN and Zheng ZQ. Detection of early pregnancy factor in fetal sera. Am J Reprod Immunol 1990; 23:69-72.
46. Athanasas-Platsis S, Morton H, Dunglison GF and Kaye PL. Antibodies to early pregnancy factor retard embryonic development in mice in vivo. J Reprod Fertil 1991; 92:443-451.
47. Cheng SJ and Zheng ZQ. Early pregnancy factor in cervical mucus of pregnant women. Am J Reprod Immunol 2004; 51:102-105.
48. Athanasas-Platsis S, Quinn KA, Wong TY, Rolfe BE, Cavanagh AC and Morton H. Passive immunization of pregnant mice against early pregnancy factor causes loss of embryonic viability. J Reprod Fertil 1989; 87:495-502.
49. Cavanagh AC. Identification of early pregnancy factor as chaperonin 10:implications for understanding its role. Rev Reprod 1996; 1:28-32.
50. Macario AJ, Cappello F, Zummo G and Conway de Macario E. Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems. Ann N Y Acad Sci 2010; 1197:85-93.
51. Morton H, McKay DA, Murphy RM, Somodevilla- Torres MJ, Swanson CE, Cassady AI, Summers KM and Cavanagh AC. Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin graft survival time in rats. Immunol Cell Biol 2000; 78:603-607.
52. Athanasas-Platsis S, Zhang B, Hillyard NC, Cavanagh AC, Csurhes PA, Morton H and McCombe PA. Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis. J Neurol Sci 2003; 214:27-36.
53. Zhang B, Walsh MD, Nguyen KB, Hillyard NC, Cavanagh AC, McCombe PA and Morton H. Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobenzene in normal BALB/c mice. J Neurol Sci 2003; 212:37-46.
54. Vanags D, Williams B, Johnson B, Hall S, Nash P, Taylor A, Weiss J and Feeney D. Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet 2006; 368:855-863.
55. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81:1-5.
56. Land WG. Injury to allografts: innate immune pathways to acute and chronic rejection. Saudi J Kidney Dis Transpl 2005; 16:520-539.
57. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K and Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104-107.
58. Pluddemann A, Neyen C and Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods 2007; 43:207-217.
59. Kaul Z, Yaguchi T, Kaul SC and Wadhwa R. Quantum dot-based protein imaging and functional significance of two mitochondrial chaperones in cellular senescence and carcinogenesis. Ann N Y Acad Sci 2006; 1067:469-473.
60. Tetu B, Popa I, Bairati I, L'Esperance S, Bachvarova M, Plante M, Harel F and Bachvarov D. Immunohistochemical analysis of possible chemoresistance markers identified by microarrays on serous ovarian carcinomas. Mod Pathol 2008; 21:1002-1010.
61. Ghobrial IM, McCormick DJ, Kaufmann SH, Leontovich AA, Loegering DA, Dai NT, Krajnik KL, Stenson MJ, Melhem MF, Novak AJ, Ansell SM and Witzig TE. Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 2005; 105:3722-3730.
62. Czarnecka AM, Campanella C, Zummo G and Cappello F. Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics. Cancer Biol Ther 2006; 5:714-720.
63. Fan L, Fan L, Ling J, Ma X, Cui YG and Liu JY. Involvement of HSP10 during the ovarian follicular development of polycystic ovary syndrome: Study in both human ovaries and cultured mouse follicles. Gynecol Endocrinol 2009; 25:392-397.
64. Cappello F, Di Stefano A, David S, Rappa F, Anzalone R, La Rocca G, D'Anna SE, Magno F, Donner CF, Balbi B and Zummo G. Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 2006; 107:2417-2424.
65. Akyol S, Gercel-Taylor C, Reynolds LC and Taylor DD. HSP-10 in ovarian cancer: expression and suppression of T-cell signaling. Gynecol Oncol 2006; 101:481-486.
66. Athanasas-Platsis S, Somodevilla-Torres MJ, Morton H and Cavanagh AC. Investigation of the immunocompetent cells that bind early pregnancy factor and preliminary studies of the early pregnancy factor target molecule. Immunol Cell Biol 2004; 82:361-369.
67. Cappello F, Rappa F, David S, Anzalone R and Zummo G. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res 2003; 23:1325-1331.
68. Rabinowich H, Suminami Y, Reichert TE, Crowley- Nowick P, Bell M, Edwards R and Whiteside TL. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. Int J Cancer 1996; 68:276-284.
69. Reichert TE, Rabinowich H, Johnson JT and Whiteside TL. Mechanisms responsible for signaling and functional defects. J Immunother 1998; 21:295-306.
70. Cheriyan VT, Krishna SM, Kumar A, Jayaprakash PG and Balaram P. Signaling defects and functional impairment in T-cells from cervical cancer patients. Cancer Biother Radiopharm 2009; 24:667-673.
71. Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, Ahmad-Nejad P, Kirschning CJ, Da Costa C, Rammensee HG, Wagner H and Schild H. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 2002; 277:20847-20853.
72. Murshid A, Gong J and Calderwood SK. Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I. J Immunol 2010; 185:2903-2917.
73. Fischer N, Haug M, Kwok WW, Kalbacher H, Wernet D, Dannecker GE and Holzer U. Involvement of CD91 and scavenger receptors in Hsp70-facilitated activation of human antigenspecific CD4+ memory T cells. Eur J Immunol 2010; 40:986-997.
74. Hromadnikova I, Nguyen TT, Zlacka D, Sedlackova L, Popelka S, Veigl D, Pech J, Vavrincova P and Sosna A. Expression of heat shock protein receptors on fibroblast-like synovial cells derived from rheumatoid arthritis-affected joints. Rheumatol Int 2008; 28:837-844.
75. Pockley AG, Fairburn B, Mirza S, Slack LK, Hopkinson K and Muthana M. A non-receptormediated mechanism for internalization of molecular chaperones. Methods 2007; 43:238-244.
76. Cappello F, Tripodo C, Farina F, Franco V and Zummo G. HSP10 selective preference for myeloid and megakaryocytic precursors in normal human bone marrow. Eur J Histochem 2004; 48:261-265.
77. Quinn KA, Cavanagh AC, Hillyard NC, McKay DA and Morton H. Early pregnancy factor in liver regeneration after partial hepatectomy in rats: relationship with chaperonin 10. Hepatology 1994; 20:1294-1302.
78. Quinn KA and Morton H. Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours. Cancer Immunol Immunother 1992; 34:265-271.
79. Shan YX, Yang TL, Mestril R and Wang PH. Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem 2003; 278:45492-45498.
80. Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R and Wang PH. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J Mol Cell Cardiol 2003; 35:1135-1143.
81. Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. Embo J 1999; 18:2040-2048.
82. Lin KM, Hollander JM, Kao VY, Lin B, Macpherson L and Dillmann WH. Myocyte protection by 10 kD heat shock protein (Hsp10) involves the mobile loop and attenuation of the Ras GTPase pathway. Faseb J 2004; 18:1004-1006.
83. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29:15-18.
84. Zhou J, Schmid T, Frank R and Brune B. PI3K/ Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHLindependent degradation. J Biol Chem 2004; 279:13506-13513.
85. Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, Mao C, Ye R, Wang M, Pen L, Dubeau L, Groshen S, Hofman FM and Lee AS. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 2008; 68:498-505.
86. Liu B, Ye D, Song X, Zhao X, Yi L, Song J, Zhang Z and Zhao Q. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis. Vaccine 2008; 26:1387-1396.
87. Okawa Y, Hideshima T, Steed P, Vallet S, Hall S, Huang K, Rice J, Barabasz A, Foley B, Ikeda H, Raje N, Kiziltepe T, Yasui H, Enatsu S and Anderson KC. SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK. Blood 2009; 113:846-855.
88. Sun J and Liao JK. Induction of angiogenesis by heat shock protein 90 mediated by protein kinase Akt and endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol 2004; 24:2238-2244.
89. Zhao HY, Ooyama A, Yamamoto M, Ikeda R, Haraguchi M, Tabata S, Furukawa T, Che XF, Zhang S, Oka T, Fukushima M, Nakagawa M, Ono M, Kuwano M and Akiyama S. Molecular basis for the induction of an angiogenesis inhibitor, thrombospondin-1, by 5-fluorouracil. Cancer Res 2008; 68:7035-7041.